Van Eck Associates Corp Dr Reddys Laboratories LTD Transaction History
Van Eck Associates Corp
- $88.3 Billion
- Q2 2025
A detailed history of Van Eck Associates Corp transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Van Eck Associates Corp holds 7,474 shares of RDY stock, worth $100,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,474
Previous 6,086
22.81%
Holding current value
$100,525
Previous $80,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding RDY
# of Institutions
260Shares Held
93.2MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.13.1MShares$176 Million0.27% of portfolio
-
Royal Bank Of Canada Toronto, A69.96MShares$134 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.01MShares$121 Million0.19% of portfolio
-
Aikya Investment Management LTD London, X06.35MShares$85.5 Million28.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.4MShares$72.6 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.23B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...